Prediction: Lilly Will Trade at Record High in 12 Months
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Get guidance on which passive funds to buy for retirement, focusing on cost, diversification, and long-term goals.
24,385 articlesEli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Promotional sign up offers can turbocharge your rewards, but they’re easy to misread. This expert guide breaks down h...
A new wave of policy and investment is aimed at loosening China’s grip on rare earth processing. Yet the bottleneck i...
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
Google expands real estate listings nationwide, extending enhanced Local Services Ads to all 50 states. Buyers gain i...
As RH prepares for the (rh) 2026 earnings call, investors want clarity on growth, margins, and strategy. This article...
Celebrities often share headlines about growing families, but behind those moments lie real financial planning. This ...
The U.S. DOJ opened the door for Paramount Skydance to acquire Warner Bros. Discovery in a $110 billion deal, signali...
Nvidia’s Jensen Huang signals a platform-first moat as Q1 FY27 revenue climbs and data center demand explodes. The co...
As AI workloads spur hyperscale data-center expansion, Vertiv’s order book signals a durable cycle that could lift th...
Chevron reports record cash flow and a durable dividend, reviving investor debate over its valuation in a volatile en...
As Meta Platforms advances a sweeping AI infrastructure plan, the stock remains a focus for investors who see the com...